2
RESEARCH METHODOLOGY
32
5
MARKET OVERVIEW
Humanized models and CRISPR revolutionize drug discovery amidst regulatory and ethical challenges.
50
5.2.1.1
RISING USE OF HUMANIZED MODELS IN DRUG DISCOVERY RESEARCH
5.2.1.2
EMERGING PRECLINICAL APPLICATIONS OF HUMANIZED MOUSE MODELS
5.2.1.3
GOVERNMENT-FUNDED INITIATIVES FOR CANCER RESEARCH
5.2.1.4
INCREASING R&D ACTIVITIES IN PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY
5.2.2.1
INTRODUCTION OF FDA MODERNIZATION ACT 2.0/3.0
5.2.2.2
STRINGENT REGULATORY COMPLIANCE FOR ETHICAL USE OF ANIMAL MODELS
5.2.3.1
GROWING PREFERENCE FOR HUMANIZED PDX MODELS
5.2.3.2
EMERGENCE OF CRISPR IN BIOMEDICAL RESEARCH
5.2.4.1
ALTERNATIVE METHODS FOR ANIMAL TESTING
5.2.4.2
LIMITATIONS OF HUMANIZED MOUSE MODELS
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4.1
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024
5.4.2
AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY REGION
5.5
SUPPLY CHAIN ANALYSIS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.2
TISSUE ENGINEERING
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.3
BIOMARKER DISCOVERY
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.3
REGENERATIVE MEDICINE
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
5.13
REGULATORY LANDSCAPE
5.13.1
REGULATORY FRAMEWORK
5.13.6
MIDDLE EAST & AFRICA
5.13.7
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14
PORTER’S FIVE FORCES ANALYSIS
5.14.1
THREAT OF NEW ENTRANTS
5.14.2
THREAT OF SUBSTITUTES
5.14.3
BARGAINING POWER OF SUPPLIERS
5.14.4
BARGAINING POWER OF BUYERS
5.14.5
INTENSITY OF COMPETITIVE RIVALRY
5.15
KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2
KEY BUYING CRITERIA, BY END USER
5.16
IMPACT OF AI ON HUMANIZED MOUSE AND RAT MODEL MARKET
5.16.2
MARKET POTENTIAL OF AI IN HUMANIZED MOUSE AND RAT MODELS
5.16.4
KEY COMPANIES IMPLEMENTING AI
5.16.5
FUTURE OF GENERATIVE AI IN HUMANIZED MOUSE AND RAT MODEL MARKET
6
HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 32 Data Tables
89
6.2
HUMANIZED MOUSE MODELS
6.2.1
GENETIC HUMANIZED MOUSE MODELS
6.2.1.1
ADVANCEMENTS IN GENETICAL ENGINEERING TECHNOLOGIES TO DRIVE MARKET
6.2.2
CELL-BASED HUMANIZED MOUSE MODELS
6.2.2.1
CD34 HUMANIZED MOUSE MODELS
6.2.2.2
PBMC HUMANIZED MOUSE MODELS
6.2.2.3
BLT HUMANIZED MOUSE MODELS
6.3.1
PREFERENCE FOR SRG RAT MODELS FOR RESEARCH STUDIES WITH LARGE SAMPLE SIZE SUPPORTS THE SEGMENT GROWTH
7
HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 14 Data Tables
107
7.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.2.1
GROWING ADOPTION OF HU-MICE MODELS IN VACCINE DEVELOPMENT TO BOOST SEGMENT GROWTH
7.3
CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS
7.3.1
OUTSOURCING OF DRUG DISCOVERY SERVICES BY PHARMA & BIOTECH COMPANIES TO PROPEL MARKET
7.4
ACADEMIC & RESEARCH INSTITUTES
7.4.1
SUPPORTIVE FUNDING INVESTMENTS FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
8
HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 25 Data Tables
116
8.2.1
UTILIZATION OF MOUSE MODELS IN CANCER RESEARCH TO DRIVE MARKET
8.3
IMMUNOLOGY AND INFECTIOUS DISEASES
8.3.1
DEVELOPMENT OF ADVANCED MODELS FOR TREATMENT OF RARE DISEASES TO DRIVE MARKET
8.4.1
RISING INCIDENCE OF CNS DISORDERS TO DRIVE MARKET
8.5.1
INCREASING CLINICAL TRIALS FOR TOXICOLOGY STUDIES TO SUPPORT MARKET GROWTH
8.6.1
RISING DEMAND FOR STEM CELL THERAPY TO DRIVE MARKET
9
HUMANIZED MOUSE AND RAT MODEL MARKET, BY REGION
Comprehensive coverage of 6 Regions with country-level deep-dive of 12 Countries | 110 Data Tables.
131
9.2.1
MACROECONOMIC OUTLOOK OF NORTH AMERICA
9.2.2.1
GROWING RESEARCH INITIATIVES ON MABS AND BIOSIMILARS TO DRIVE MARKET
9.2.3.1
GOVERNMENT INITIATIVES ON STEM CELL RESEARCH TO DRIVE MARKET
9.3.1
MACROECONOMIC OUTLOOK OF EUROPE
9.3.2.1
RISING PHARMACEUTICAL R&D EXPENDITURE TO DRIVE MARKET
9.3.3.1
GROWING INVESTMENTS IN CANCER RESEARCH TO DRIVE MARKET
9.3.4.1
RISING INITIATIVES FOR GENOMICS RESEARCH TO SUPPORT MARKET GROWTH
9.3.5.1
ROBUST PHARMACEUTICAL PRODUCTION TO FUEL MARKET
9.3.6.1
RISING GROWTH IN BIOTECH INDUSTRY TO DRIVE MARKET
9.4.1
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
9.4.2.1
HIGH GROWTH IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
9.4.3.1
GROWING RESEARCH COLLABORATIONS AMONG PHARMACEUTICAL COMPANIES TO DRIVE MARKET
9.4.4.1
GROWTH IN BIOTECH INDUSTRY TO DRIVE MARKET
9.4.5.1
RISING GOVERNMENT-FUNDED INVESTMENTS FOR PHARMACEUTICAL R&D TO DRIVE MARKET
9.4.6.1
RISING BIOMEDICAL RESEARCH PROJECTS TO DRIVE MARKET
9.4.7
REST OF ASIA PACIFIC
9.5.1
GROWING PRESENCE OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO PROPEL MARKET
9.5.2
MACROECONOMIC OUTLOOK OF LATIN AMERICA
9.6.1
GROWING PHARMACEUTICAL MARKET IN COUNTRIES TO SUPPORT MARKET GROWTH
9.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
9.7.1
GROWING PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
9.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
10
COMPETITIVE LANDSCAPE
Analyze strategic maneuvers and market dominance of key players in humanized model markets.
184
10.2
KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HUMANIZED MOUSE AND RAT MODEL MARKET
10.3
REVENUE ANALYSIS, 2020−2024
10.4
MARKET SHARE ANALYSIS, 2024
10.4.1
HUMANIZED MOUSE AND RAT MODEL MARKET
10.5
COMPANY VALUATION AND FINANCIAL METRICS
10.6
BRAND/PRODUCT COMPARISON
10.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.7.5.1
COMPANY FOOTPRINT
10.7.5.2
REGION FOOTPRINT
10.7.5.4
APPLICATION FOOTPRINT
10.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.8.1
PROGRESSIVE COMPANIES
10.8.2
RESPONSIVE COMPANIES
10.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES
10.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
10.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.9
COMPETITIVE SCENARIO
10.9.1
PRODUCT LAUNCHES & APPROVALS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
205
11.1.1
CHARLES RIVER LABORATORIES
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
PRODUCTS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.2
THE JACKSON LABORATORY
11.1.5
TACONIC BIOSCIENCES, INC.
11.1.7
CHAMPIONS ONCOLOGY, INC.
11.1.9
VITALSTAR BIOTECHNOLOGY
11.1.10
INGENIOUS TARGETING LABORATORY
11.1.12
ONCODESIGN SERVICES
11.1.13
PHARMATEST SERVICES
11.2.5
TRANSCURE BIOSERVICES
11.2.7
ARAGEN LIFE SCIENCES LTD.
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
TABLE 1
HUMANIZED MOUSE AND RAT MODEL MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
IMPACT ANALYSIS OF SUPPLY AND DEMAND-SIDE FACTORS
TABLE 3
HUMANIZED MOUSE AND RAT MODEL MARKET: RISK ANALYSIS
TABLE 4
HUMANIZED MOUSE AND RAT MODEL MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 5
NUMBER OF R&D PRODUCTS, BY INDICATION (2024)
TABLE 6
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 (USD MILLION)
TABLE 7
AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY REGION, 2022–2024 (USD)
TABLE 8
AVERAGE SELLING PRICE TREND OF KEY PRODUCTS (HUMANIZED MOUSE MODELS), BY REGION, 2022–2024 (USD)
TABLE 9
HUMANIZED MOUSE AND RAT MODEL MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10
INVESTMENT AND FUNDING ACTIVITY, BY KEY PLAYER, 2021−2025
TABLE 11
HUMANIZED MOUSE AND RAT MODEL MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2024
TABLE 12
IMPORT DATA FOR LABORATORY MOUSE
TABLE 13
EXPORT DATA FOR LABORATORY MOUSE
TABLE 14
HUMANIZED MOUSE AND RAT MODEL MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
HUMANIZED MOUSE AND RAT MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 20
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 21
KEY BUYING CRITERIA, BY END USER
TABLE 22
HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 23
HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 24
HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 25
HUMANIZED MOUSE MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 26
NORTH AMERICA: HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 27
EUROPE: HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28
ASIA PACIFIC: HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
GENETIC HUMANIZED MOUSE MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
NORTH AMERICA: GENETIC HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
EUROPE: GENETIC HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32
ASIA PACIFIC: GENETIC HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
NORTH AMERICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
EUROPE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
ASIA PACIFIC: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
CD34 HUMANIZED MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
NORTH AMERICA: CD34 HUMANIZED MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
EUROPE: CD34 HUMANIZED MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
ASIA PACIFIC: CD34 HUMANIZED MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
PBMC HUMANIZED MICE MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
NORTH AMERICA: PBMC HUMANIZED MICE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
EUROPE: PBMC HUMANIZED MICE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
ASIA PACIFIC: PBMC HUMANIZED MICE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
BLT HUMANIZED MOUSE MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
NORTH AMERICA: BLT HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
EUROPE: BLT HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
ASIA PACIFIC: BLT HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
HUMANIZED RAT MODELS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
NORTH AMERICA: HUMANIZED RAT MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
EUROPE: HUMANIZED RAT MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
ASIA PACIFIC: HUMANIZED RAT MODELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 55
USE OF HUMANIZED MICE MODELS IN DEVELOPED AND TESTED VACCINES
TABLE 56
HUMANIZED MOUSE AND RAT MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
HUMANIZED MOUSE AND RAT MODEL MARKET FOR CROS AND CDMOS, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
HUMANIZED MOUSE AND RAT MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 69
HUMANIZED MOUSE AND RAT MODEL MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
HUMANIZED MOUSE AND RAT MODEL MARKET FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
HUMANIZED MOUSE AND RAT MODEL MARKET FOR NEUROSCIENCE, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81
HUMANIZED MOUSE AND RAT MODEL MARKET FOR TOXICOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 82
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR TOXICOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR TOXICOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR TOXICOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
HUMANIZED MOUSE AND RAT MODEL MARKET FOR HEMATOPOIESIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR HEMATOPOIESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR HEMATOPOIESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR HEMATOPOIESIS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
HUMANIZED MOUSE AND RAT MODEL MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
HUMANIZED MOUSE AND RAT MODEL MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
NORTH AMERICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
NORTH AMERICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 99
NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 100
KEY MACROECONOMIC INDICATORS OF NORTH AMERICA
TABLE 101
US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
US: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
US: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 105
US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 106
CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
CANADA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
CANADA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 110
CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 111
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
EUROPE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
EUROPE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 116
EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 117
KEY MACROECONOMIC INDICATORS OF EUROPE
TABLE 118
GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
GERMANY: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
GERMANY: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 122
GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123
UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
UK: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
UK: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 127
UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 128
FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
FRANCE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 130
FRANCE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 132
FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 133
ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
ITALY: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135
ITALY: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 137
ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 138
SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
SPAIN: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
SPAIN: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 142
SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 143
REST OF EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
REST OF EUROPE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
REST OF EUROPE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
REST OF EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 147
REST OF EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 148
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
ASIA PACIFIC: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
ASIA PACIFIC: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 153
ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 154
KEY MACROECONOMIC INDICATORS OF ASIA PACIFIC
TABLE 155
CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
CHINA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
CHINA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 159
CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
JAPAN: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
JAPAN: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 164
JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 165
INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
INDIA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
INDIA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 169
INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 170
SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
SOUTH KOREA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
SOUTH KOREA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 174
SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 175
AUSTRALIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
AUSTRALIA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
AUSTRALIA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
AUSTRALIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 179
AUSTRALIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 180
REST OF ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
REST OF ASIA PACIFIC: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
REST OF ASIA PACIFIC: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
REST OF ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 185
LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
LATIN AMERICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
LATIN AMERICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 189
LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 190
KEY MACROECONOMIC INDICATORS OF LATIN AMERICA
TABLE 191
MIDDLE EAST: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
MIDDLE EAST: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
MIDDLE EAST: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
MIDDLE EAST: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 195
MIDDLE EAST: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 196
KEY MACROECONOMIC INDICATORS OF MIDDLE EAST
TABLE 197
AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
AFRICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
AFRICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 201
AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 202
KEY MACROECONOMIC INDICATORS OF AFRICA
TABLE 203
STRATEGIES ADOPTED BY KEY PLAYERS IN HUMANIZED MOUSE AND RAT MODEL MARKET, 2021−2024
TABLE 204
HUMANIZED MOUSE AND RAT MODEL MARKET: DEGREE OF COMPETITION
TABLE 205
HUMANIZED MOUSE AND RAT MODEL MARKET: REGION FOOTPRINT
TABLE 206
HUMANIZED MOUSE AND RAT MODEL MARKET: TYPE FOOTPRINT
TABLE 207
HUMANIZED MOUSE AND RAT MODEL MARKET: APPLICATION FOOTPRINT
TABLE 208
HUMANIZED MOUSE AND RAT MODEL MARKET: KEY STARTUPS/SMES
TABLE 209
HUMANIZED MOUSE AND RAT MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES
TABLE 210
HUMANIZED MOUSE AND RAT MODEL MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
TABLE 211
HUMANIZED MOUSE AND RAT MODEL MARKET: DEALS, JANUARY 2021–MARCH 2025
TABLE 212
HUMANIZED MOUSE AND RAT MODEL MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025
TABLE 213
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 214
CHARLES RIVER LABORATORIES: PRODUCTS OFFERED
TABLE 215
CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–JANUARY 2025
TABLE 216
CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 217
THE JACKSON LABORATORY: COMPANY OVERVIEW
TABLE 218
THE JACKSON LABORATORY: PRODUCTS OFFERED
TABLE 219
THE JACKSON LABORATORY: DEALS, JANUARY 2021–JANUARY 2025
TABLE 220
INOTIV: COMPANY OVERVIEW
TABLE 221
INOTIV: PRODUCTS OFFERED
TABLE 222
INOTIV: DEALS, JANUARY 2021–JANUARY 2025
TABLE 223
GENOWAY: COMPANY OVERVIEW
TABLE 224
GENOWAY: PRODUCTS OFFERED
TABLE 225
GENOWAY: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 226
TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 227
TACONIC BIOSCIENCES, INC.: PRODUCTS OFFERED
TABLE 228
TACONIC BIOSCIENCES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
TABLE 229
TACONIC BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
TABLE 230
JSR CORPORATION: COMPANY OVERVIEW
TABLE 231
JSR CORPORATION: PRODUCTS OFFERED
TABLE 232
JSR CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
TABLE 233
JSR CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025
TABLE 234
CHAMPIONS ONCOLOGY, INC.: COMPANY OVERVIEW
TABLE 235
CHAMPIONS ONCOLOGY, INC.: PRODUCTS OFFERED
TABLE 236
JANVIER LABS: COMPANY OVERVIEW
TABLE 237
JANVIER LABS: PRODUCTS OFFERED
TABLE 238
JANVIER LABS: DEALS, JANUARY 2021–JANUARY 2025
TABLE 239
VITALSTAR BIOTECHNOLOGY: COMPANY OVERVIEW
TABLE 240
VITALSTAR BIOTECHNOLOGY: PRODUCTS OFFERED
TABLE 241
INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW
TABLE 242
INGENIOUS TARGETING LABORATORY: PRODUCTS OFFERED
TABLE 243
HARBOUR BIOMED: COMPANY OVERVIEW
TABLE 244
HARBOUR BIOMED: PRODUCTS OFFERED
TABLE 245
HARBOUR BIOMED: DEALS, JANUARY 2021–JANUARY 2025
TABLE 246
ONCODESIGN SERVICES: COMPANY OVERVIEW
TABLE 247
ONCODESIGN SERVICES: PRODUCTS OFFERED
TABLE 248
PHARMATEST SERVICES: COMPANY OVERVIEW
TABLE 249
PHARMATEST SERVICES: PRODUCTS OFFERED
TABLE 250
OZGENE PTY LTD.: COMPANY OVERVIEW
TABLE 251
CLEA JAPAN, INC.: COMPANY OVERVIEW
TABLE 252
ALTOGEN LABS: COMPANY OVERVIEW
TABLE 253
REACTION BIOLOGY: COMPANY OVERVIEW
TABLE 254
TRANSCURE BIOSERVICES: COMPANY OVERVIEW
TABLE 255
CYAGEN: COMPANY OVERVIEW
TABLE 256
ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
TABLE 257
BIOCYTOGEN: COMPANY OVERVIEW
TABLE 258
GEMPHARMATECH: COMPANY OVERVIEW
FIGURE 1
HUMANIZED MOUSE AND RAT MODEL MARKET SEGMENTATION AND REGIONS CONSIDERED
FIGURE 2
HUMANIZED MOUSE AND RAT MODEL MARKET: YEARS CONSIDERED
FIGURE 3
HUMANIZED MOUSE AND RAT MODEL MARKET: RESEARCH DESIGN
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: BY RESPONDENT, DESIGNATION, AND REGION
FIGURE 5
GLOBAL HUMANIZED MOUSE AND RAT MODEL MARKET SIZE ESTIMATION, 2024
FIGURE 6
COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2024
FIGURE 7
REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES, 2024
FIGURE 8
MARKET SIZE VALIDATION FROM PRIMARIES
FIGURE 9
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10
HUMANIZED MOUSE AND RAT MODEL MARKET: CAGR PROJECTIONS, 2025–2030
FIGURE 11
HUMANIZED MOUSE AND RAT MODEL MARKET: DATA TRIANGULATION
FIGURE 12
HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 13
HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 14
HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 15
REGIONAL SNAPSHOT OF HUMANIZED MOUSE AND RAT MODEL MARKET, 2025–2030
FIGURE 16
RISING USE OF HUMANIZED MODELS IN DRUG DISCOVERY RESEARCH TO DRIVE MARKET
FIGURE 17
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2024
FIGURE 18
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 19
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2024
FIGURE 20
HUMANIZED MOUSE AND RAT MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21
NUMBER OF CLINICAL TRIALS REGISTERED FOR CANCER IMMUNOTHERAPIES, 2020–2024
FIGURE 22
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 23
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
FIGURE 24
AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY REGION, 2022–2024 (USD)
FIGURE 25
AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY REGION, 2022–2024 (USD)
FIGURE 26
HUMANIZED MOUSE AND RAT MODEL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 27
HUMANIZED MOUSE AND RAT MODEL MARKET: VALUE CHAIN ANALYSIS
FIGURE 28
HUMANIZED MOUSE AND RAT MODEL MARKET ECOSYSTEM
FIGURE 29
INVESTMENT AND FUNDING SCENARIO, 2021–2025
FIGURE 30
HUMANIZED MOUSE AND RAT MODEL MARKET: PATENT ANALYSIS, 2014–2024
FIGURE 31
HUMANIZED MOUSE AND RAT MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 32
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 33
KEY BUYING CRITERIA, BY END USER
FIGURE 35
HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)
FIGURE 36
HUMANIZED MOUSE AND RAT MODEL MARKET: NORTH AMERICA SNAPSHOT
FIGURE 37
HUMANIZED MOUSE AND RAT MODEL MARKET: ASIA PACIFIC SNAPSHOT
FIGURE 38
REVENUE ANALYSIS OF KEY PLAYERS IN HUMANIZED MOUSE AND RAT MODEL MARKET, 2020−2024
FIGURE 39
MARKET SHARE ANALYSIS OF HUMANIZED MOUSE AND RAT MODEL MARKET, 2024
FIGURE 40
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 41
COMPANY VALUATION AND FINANCIAL METRICS, 2024
FIGURE 42
HUMANIZED MOUSE AND RAT MODEL MARKET: BRAND/PRODUCT COMPARISON
FIGURE 43
HUMANIZED MOUSE AND RAT MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 44
HUMANIZED MOUSE AND RAT MODEL MARKET: COMPANY FOOTPRINT
FIGURE 45
HUMANIZED MOUSE AND RAT MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 46
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
FIGURE 47
THE JACKSON LABORATORY: COMPANY SNAPSHOT (2024)
FIGURE 48
INOTIV: COMPANY SNAPSHOT (2024)
FIGURE 49
JSR CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 50
CHAMPIONS ONCOLOGY, INC.: COMPANY SNAPSHOT (2024)
FIGURE 51
HARBOUR BIOMED: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Humanized Mouse and Rat Model Market